|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Total credit card and other loans (includes loans available to settle obligations of consolidated variable interest entities March 31, 2024, $12,058; December 31, 2023, $12,844, respectively) | ||||||||||||||||||||
| Total credit card and other loans (includes loans available to settle obligations of consolidated variable interest entities: September 30, 2026, $11,489; December 31, 2025, $10,708) | ||||||||||||||||||||
| Allowance for credit losses | ||||||||||||||||||||
| Credit card and other loans, net | ||||||||||||||||||||
| Investments (includes investment securities carried at fair value: September 30, 2026, $201; December 31, 2025, $221) | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Goodwill and intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Deposits | ||||||||||||||||||||
| Debt issued by consolidated variable interest entities | ||||||||||||||||||||
| Long-term and other debt | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Preferred stock, $0.01 par value; authorized, 210.0 thousand shares; issued and outstanding: 210.0 thousand shares as of September 30, 2026 and 75.0 thousand shares as of December 31, 2025 | ||||||||||||||||||||
| Common stock, $0.01 par value; authorized, 200.0 million shares; issued and outstanding: 38.0 million shares as of September 30, 2026 and 44.1 million shares as of December 31, 2025. | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
